ATE180278T1 - Auf dem gb-protein des marek's disease virus (mdv) basierende, rekombinante impfstoffe - Google Patents
Auf dem gb-protein des marek's disease virus (mdv) basierende, rekombinante impfstoffeInfo
- Publication number
- ATE180278T1 ATE180278T1 AT89910900T AT89910900T ATE180278T1 AT E180278 T1 ATE180278 T1 AT E180278T1 AT 89910900 T AT89910900 T AT 89910900T AT 89910900 T AT89910900 T AT 89910900T AT E180278 T1 ATE180278 T1 AT E180278T1
- Authority
- AT
- Austria
- Prior art keywords
- mdv
- disease virus
- marek
- hsv
- gene
- Prior art date
Links
- 241000701047 Gallid alphaherpesvirus 2 Species 0.000 title abstract 7
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 108010008038 Synthetic Vaccines Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 229940124551 recombinant vaccine Drugs 0.000 title 1
- 241001502481 Meleagrid alphaherpesvirus 1 Species 0.000 abstract 4
- 102000006601 Thymidine Kinase Human genes 0.000 abstract 3
- 108020004440 Thymidine kinase Proteins 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 241000700588 Human alphaherpesvirus 1 Species 0.000 abstract 1
- 108700002232 Immediate-Early Genes Proteins 0.000 abstract 1
- 102000000505 Ribonucleotide Reductases Human genes 0.000 abstract 1
- 108010041388 Ribonucleotide Reductases Proteins 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 101150002378 gC gene Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/255—Marek's disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0093—Oxidoreductases (1.) acting on CH or CH2 groups (1.17)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
- C12N9/1211—Thymidine kinase (2.7.1.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16041—Use of virus, viral particle or viral elements as a vector
- C12N2710/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16341—Use of virus, viral particle or viral elements as a vector
- C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888821441A GB8821441D0 (en) | 1988-09-13 | 1988-09-13 | Viral vectors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE180278T1 true ATE180278T1 (de) | 1999-06-15 |
Family
ID=10643510
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89910900T ATE180278T1 (de) | 1988-09-13 | 1989-09-13 | Auf dem gb-protein des marek's disease virus (mdv) basierende, rekombinante impfstoffe |
| AT99114400T ATE422543T1 (de) | 1988-09-13 | 1989-09-13 | Virale nukleotidsequenzen |
| AT96108830T ATE317439T1 (de) | 1988-09-13 | 1989-09-13 | Virale vakzine |
| AT98121028T ATE454453T1 (de) | 1988-09-13 | 1989-09-13 | Virale nukleotidsequenzen |
| AT89910146T ATE190658T1 (de) | 1988-09-13 | 1989-09-13 | Virale nucleotidsequenzen |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99114400T ATE422543T1 (de) | 1988-09-13 | 1989-09-13 | Virale nukleotidsequenzen |
| AT96108830T ATE317439T1 (de) | 1988-09-13 | 1989-09-13 | Virale vakzine |
| AT98121028T ATE454453T1 (de) | 1988-09-13 | 1989-09-13 | Virale nukleotidsequenzen |
| AT89910146T ATE190658T1 (de) | 1988-09-13 | 1989-09-13 | Virale nucleotidsequenzen |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US5906821A (de) |
| EP (3) | EP0974659B1 (de) |
| JP (6) | JP3334077B2 (de) |
| AT (5) | ATE180278T1 (de) |
| CA (2) | CA1341308C (de) |
| DE (5) | DE68929181T2 (de) |
| GB (1) | GB8821441D0 (de) |
| IE (1) | IE20000411A1 (de) |
| IL (1) | IL91628A (de) |
| ZA (2) | ZA896987B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8821441D0 (en) * | 1988-09-13 | 1988-10-12 | Animal Health Inst | Viral vectors |
| US6875856B2 (en) | 1993-09-24 | 2005-04-05 | Syntro Corporation | Recombinant infectious laryngotracheitis virus and uses thereof |
| AU6698900A (en) * | 1999-07-16 | 2001-02-05 | Agricultural Research Service | Live recombinant vaccine against avian leukosis virus using a marek's disease virus (mdv) virus as vector |
| EP1178111A1 (de) | 2000-08-03 | 2002-02-06 | Lohmann Animal Health GmbH & Co. KG | Impfung gegen Wirtzelle-assoziierte Herpesviren |
| US8195137B2 (en) * | 2008-05-09 | 2012-06-05 | Microsoft Corporation | Updating contact information for mobile traffic |
| CA2725435C (en) * | 2009-12-15 | 2023-01-03 | University Of Saskatchewan | Vaccines for inclusion body hepatitis |
| US10809780B2 (en) | 2017-03-13 | 2020-10-20 | Samsung Electronics Co., Ltd. | Active disturbance rejection based thermal control |
| US10698460B2 (en) | 2017-03-13 | 2020-06-30 | Samsung Electronics Co., Ltd. | Advanced thermal control for SSD |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4603112A (en) * | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
| US4722848A (en) * | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
| WO1984002077A1 (en) * | 1982-11-30 | 1984-06-07 | Us Health | Process for producing poxvirus recombinants for expression of foreign genes |
| US5928648A (en) * | 1985-09-06 | 1999-07-27 | Syntro Corporation | Recombinant herpesvirus of turkeys and uses thereof |
| US4679330A (en) * | 1985-12-12 | 1987-07-14 | Williams Kenneth L | Concentricity gauge |
| AU623333B2 (en) * | 1986-01-27 | 1992-05-14 | Syntro Corporation | Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same |
| AU619181B2 (en) | 1987-03-19 | 1992-01-23 | Synergen, Inc. | Viral vector system for the introduction of foreign dna expression products into gallinaceous birds |
| CA1337120C (en) * | 1987-07-27 | 1995-09-26 | Mark D. Cochran | Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccines containing same |
| JP2779447B2 (ja) * | 1988-03-20 | 1998-07-23 | 財団法人阪大微生物病研究会 | 弱毒マレック病ウイルス・ベクターを用いる組換え遺伝子作成法、及び該ウイルスの組換え体 |
| GB8821441D0 (en) * | 1988-09-13 | 1988-10-12 | Animal Health Inst | Viral vectors |
| AU2946395A (en) | 1994-06-30 | 1996-01-25 | Board of Regents of the University of Illinois, The | Recombinant infectious laryngotracheitis virus and vaccine |
| CA2216139C (en) | 1995-03-23 | 2013-01-08 | Syntro Corporation | Recombinant infectious laryngotracheitis virus and uses thereof |
-
1988
- 1988-09-13 GB GB888821441A patent/GB8821441D0/en active Pending
-
1989
- 1989-09-12 IE IE20000411A patent/IE20000411A1/en not_active Application Discontinuation
- 1989-09-13 DE DE68929181T patent/DE68929181T2/de not_active Expired - Lifetime
- 1989-09-13 DE DE68929000T patent/DE68929000T2/de not_active Expired - Lifetime
- 1989-09-13 CA CA000611210A patent/CA1341308C/en not_active Expired - Lifetime
- 1989-09-13 DE DE68929564T patent/DE68929564D1/de not_active Expired - Lifetime
- 1989-09-13 AT AT89910900T patent/ATE180278T1/de active
- 1989-09-13 AT AT99114400T patent/ATE422543T1/de not_active IP Right Cessation
- 1989-09-13 IL IL9162889A patent/IL91628A/en not_active IP Right Cessation
- 1989-09-13 ZA ZA896987A patent/ZA896987B/xx unknown
- 1989-09-13 DE DE68929567T patent/DE68929567D1/de not_active Expired - Lifetime
- 1989-09-13 EP EP99114400A patent/EP0974659B1/de not_active Expired - Lifetime
- 1989-09-13 EP EP98121028A patent/EP0908517B1/de not_active Expired - Lifetime
- 1989-09-13 CA CA000611209A patent/CA1341307C/en not_active Expired - Lifetime
- 1989-09-13 DE DE68929544T patent/DE68929544T2/de not_active Expired - Lifetime
- 1989-09-13 AT AT96108830T patent/ATE317439T1/de not_active IP Right Cessation
- 1989-09-13 ZA ZA896986A patent/ZA896986B/xx unknown
- 1989-09-13 AT AT98121028T patent/ATE454453T1/de not_active IP Right Cessation
- 1989-09-13 AT AT89910146T patent/ATE190658T1/de not_active IP Right Cessation
- 1989-09-13 EP EP00105894A patent/EP1022338A3/de not_active Ceased
-
1993
- 1993-09-22 US US08/125,039 patent/US5906821A/en not_active Expired - Lifetime
-
1995
- 1995-06-02 US US08/460,257 patent/US5965435A/en not_active Expired - Lifetime
-
1998
- 1998-08-13 US US09/133,409 patent/US6204045B1/en not_active Expired - Lifetime
-
1999
- 1999-02-18 JP JP08214499A patent/JP3334077B2/ja not_active Expired - Lifetime
- 1999-02-18 JP JP08214399A patent/JP3334076B2/ja not_active Expired - Lifetime
- 1999-05-04 US US09/304,110 patent/US6514754B1/en not_active Expired - Fee Related
-
2000
- 2000-02-10 JP JP2000033734A patent/JP2000245489A/ja active Pending
- 2000-08-21 JP JP2000250149A patent/JP3727521B2/ja not_active Expired - Lifetime
- 2000-11-24 JP JP2000358278A patent/JP3513481B2/ja not_active Expired - Lifetime
- 2000-12-26 US US09/745,810 patent/US6413762B2/en not_active Expired - Lifetime
-
2005
- 2005-06-08 JP JP2005168892A patent/JP2005312458A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0748631A3 (de) | Virale Vakzine | |
| CA2031164A1 (en) | Recombinant herpesvirus of turkeys and live vector vaccines derived thereof | |
| KR880700070A (ko) | 비루스 왁찐 | |
| CA2166367A1 (en) | Live recombinant avian vaccine using an avian herpesvirus as vector | |
| EP1026246A4 (de) | Rekombinanten des infektiösen vogel-herpesvirus und rekombinante impfstoffe, die unter dessen verwendung hergestellt wurden | |
| ATE180278T1 (de) | Auf dem gb-protein des marek's disease virus (mdv) basierende, rekombinante impfstoffe | |
| EP0319570A4 (en) | Recombinant human cytomegalovirus containing foreign gene and use thereof | |
| LU91303I2 (fr) | Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP | |
| HU228262B1 (en) | Vaccination against host cell-associated herpesviruses | |
| EP0351418A4 (de) | Virales vektorsystem zum einführen fremder dns-expressionserzeugnisse in gallinaceenvögeln. | |
| DK0606452T3 (da) | Vektorvacciner fra rekombinant katteherpesvirus | |
| CA2196416A1 (en) | Recombinant herpes virus with gb gene promoter | |
| EP0623172A4 (de) | Rekombinanter poxvirus als impfstoff gegen der virus der marek-krankheit. | |
| Sussman et al. | The identification of an African swine fever gene with conserved helicase motifs and a striking homology to herpes virus origin binding protein, UL9. |